David A. Pearce

7.8k total citations
171 papers, 6.0k citations indexed

About

David A. Pearce is a scholar working on Physiology, Molecular Biology and Cell Biology. According to data from OpenAlex, David A. Pearce has authored 171 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Physiology, 88 papers in Molecular Biology and 58 papers in Cell Biology. Recurrent topics in David A. Pearce's work include Lysosomal Storage Disorders Research (96 papers), Cellular transport and secretion (52 papers) and Calcium signaling and nucleotide metabolism (22 papers). David A. Pearce is often cited by papers focused on Lysosomal Storage Disorders Research (96 papers), Cellular transport and secretion (52 papers) and Calcium signaling and nucleotide metabolism (22 papers). David A. Pearce collaborates with scholars based in United States, United Kingdom and Germany. David A. Pearce's co-authors include Fred Sherman, Attila Kovács, Denia Ramirez‐Montealegre, Jill M. Weimer, Jonathan D. Cooper, Norman Miller, Subrata Chattopadhyay, Jared W. Benedict, S. Hossein Fatemi and Andrew I. Brooks and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

David A. Pearce

167 papers receiving 5.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David A. Pearce 2.9k 2.9k 2.0k 618 603 171 6.0k
Marc C. Patterson 2.3k 0.8× 3.4k 1.2× 874 0.4× 737 1.2× 533 0.9× 172 6.5k
Forbes D. Porter 4.4k 1.5× 2.5k 0.9× 910 0.5× 719 1.2× 1.4k 2.3× 213 8.6k
Eiji Nanba 2.2k 0.8× 1.9k 0.6× 805 0.4× 684 1.1× 645 1.1× 223 5.2k
Marie T. Vanier 2.7k 0.9× 6.8k 2.3× 1.7k 0.9× 1.6k 2.6× 427 0.7× 141 9.3k
Weiping Han 3.6k 1.2× 1.4k 0.5× 1.6k 0.8× 741 1.2× 517 0.9× 169 6.5k
Sarah E. Ross 5.5k 1.9× 3.2k 1.1× 587 0.3× 1.4k 2.3× 757 1.3× 84 10.3k
Yoshitomo Oka 6.1k 2.1× 2.4k 0.8× 2.6k 1.3× 1.8k 2.9× 1.7k 2.8× 193 12.4k
Robert Feil 6.0k 2.1× 2.5k 0.9× 602 0.3× 410 0.7× 799 1.3× 160 10.6k
Ellen Sidransky 3.4k 1.2× 9.0k 3.1× 6.0k 3.0× 1.8k 3.0× 523 0.9× 235 12.5k
Angeleen Fleming 2.2k 0.7× 791 0.3× 1.4k 0.7× 1.9k 3.1× 250 0.4× 57 5.1k

Countries citing papers authored by David A. Pearce

Since Specialization
Citations

This map shows the geographic impact of David A. Pearce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Pearce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Pearce more than expected).

Fields of papers citing papers by David A. Pearce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Pearce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Pearce. The network helps show where David A. Pearce may publish in the future.

Co-authorship network of co-authors of David A. Pearce

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Pearce. A scholar is included among the top collaborators of David A. Pearce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Pearce. David A. Pearce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaocong, David A. Pearce, Gareth Baynam, et al.. (2025). Digital health technology use in clinical trials of rare diseases: a systematic review. Communications Medicine. 5(1). 449–449.
2.
Kovács, Attila, José L. González-Hernández, & David A. Pearce. (2023). Acidified drinking water improves motor function, prevents tremors and changes disease trajectory in Cln2R207X mice, a model of late infantile Batten disease. Scientific Reports. 13(1). 19229–19229. 2 indexed citations
3.
Swier, Vicki J., Katherine A. White, Tyler B. Johnson, et al.. (2023). A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes. Disease Models & Mechanisms. 16(8). 5 indexed citations
4.
Hayes, Matthew, Meredith Hayes, John P. Furia, et al.. (2023). Management of partial-thickness rotator cuff tears with autologous adipose-derived regenerative cells is safe and more effective than injection of corticosteroid. Scientific Reports. 13(1). 19348–19348. 5 indexed citations
5.
Garrido‐Estepa, Macarena, Daniel O’Connor, Rima Nabbout, et al.. (2023). Targeting shared molecular etiologies to accelerate drug development for rare diseases. EMBO Molecular Medicine. 15(7). e17159–e17159. 19 indexed citations
6.
Anthony, J, Johan Smith, Lyndsay M. Murray, et al.. (2023). Commentary on the published position statement regarding the pathogenesis of fetal basal ganglia- thalamic hypoxic-ischaemic injury. South African Medical Journal. 114(1). 6–10. 1 indexed citations
7.
Chan, Chun‐Hung, et al.. (2022). Recommendations from the IRDiRC Working Group on methodologies to assess the impact of diagnoses and therapies on rare disease patients. Orphanet Journal of Rare Diseases. 17(1). 181–181. 20 indexed citations
8.
Schmitz, Christoph, Christopher Alt, David A. Pearce, et al.. (2022). Methodological Flaws in Meta-Analyses of Clinical Studies on the Management of Knee Osteoarthritis with Stem Cells: a Systematic Review. Preprints.org. 7 indexed citations
9.
Wang, Chiuhui Mary, Daria Julkowska, Chun‐Hung Chan, David A. Pearce, & Lucía Monaco. (2021). COVID-19 and rare diseases: reflections and recommendations by the International Rare Diseases Research Consortium. 2 indexed citations
10.
Johnson, Tyler B., Jacob T. Cain, Katherine A. White, et al.. (2019). Therapeutic landscape for Batten disease: current treatments and future prospects. Nature Reviews Neurology. 15(3). 161–178. 119 indexed citations
11.
Johnson, Tyler B., et al.. (2019). Changes in motor behavior, neuropathology, and gut microbiota of a Batten disease mouse model following administration of acidified drinking water. Scientific Reports. 9(1). 14962–14962. 19 indexed citations
12.
Grünewald, Benedikt, Maren D. Lange, Christian Werner, et al.. (2017). Defective synaptic transmission causes disease signs in a mouse model of juvenile neuronal ceroid lipofuscinosis. eLife. 6. 29 indexed citations
13.
Cárcel‐Trullols, Jaime, Attila Kovács, & David A. Pearce. (2017). Role of the Lysosomal Membrane Protein, CLN3, in the Regulation of Cathepsin D Activity. Journal of Cellular Biochemistry. 118(11). 3883–3890. 19 indexed citations
14.
Pearce, David A., et al.. (2008). Analysis of NCL Proteins from an Evolutionary Standpoint. Current Genomics. 9(2). 115–136. 10 indexed citations
15.
Wolfe, Devin M., et al.. (2007). Absence of Btn1p in the yeast model for juvenile Batten disease may cause arginine to become toxic to yeast cells. Human Molecular Genetics. 16(9). 1007–1016. 18 indexed citations
16.
Pearce, David A., et al.. (2006). You say lipofuscin, we say ceroid: Defining autofluorescent storage material. Neurobiology of Aging. 27(4). 576–588. 171 indexed citations
17.
Padilla‐Lopez, Sergio & David A. Pearce. (2006). Saccharomyces cerevisiae Lacking Btn1p Modulate Vacuolar ATPase Activity to Regulate pH Imbalance in the Vacuole. Journal of Biological Chemistry. 281(15). 10273–10280. 71 indexed citations
18.
Chattopadhyay, Subrata, Paul M. Roberts, & David A. Pearce. (2003). The yeast model for Batten disease: a role for Btn2p in the trafficking of the Golgi-associated vesicular targeting protein, Yif1p. Biochemical and Biophysical Research Communications. 302(3). 534–538. 40 indexed citations
19.
Pearce, David A., et al.. (2002). Prediction of biologically significant components from microarray data:Independently Consistent Expression Discriminator (ICED). Bioinformatics. 19(1). 62–70. 26 indexed citations
20.
Pearce, David A. & Fred Sherman. (1999). Toxicity of Copper, Cobalt, and Nickel Salts Is Dependent on Histidine Metabolism in the YeastSaccharomyces cerevisiae. Journal of Bacteriology. 181(16). 4774–4779. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc C. Patterson Breakdown of academic impact, for papers by Forbes D. Porter Breakdown of academic impact, for papers by Eiji Nanba Breakdown of academic impact, for papers by Marie T. Vanier Breakdown of academic impact, for papers by Weiping Han Breakdown of academic impact, for papers by Sarah E. Ross Breakdown of academic impact, for papers by Yoshitomo Oka Breakdown of academic impact, for papers by Robert Feil Breakdown of academic impact, for papers by Ellen Sidransky Breakdown of academic impact, for papers by Angeleen Fleming
Rankless by CCL
2026